Cargando…
Recombinant Human Erythropoietin Therapy for a Jehovah's Witness Child With Severe Anemia due to Hemolytic-Uremic Syndrome
Patients with hemolytic-uremic syndrome (HUS) can rapidly develop profound anemia as the disease progresses, as a consequence of red blood cell (RBC) hemolysis and inadequate erythropoietin synthesis. Therefore, RBC transfusion should be considered in HUS patients with severe anemia to avoid cardiac...
Autores principales: | Woo, Da Eun, Lee, Jae Min, Kim, Yu Kyung, Park, Yong Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Pediatric Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4781730/ https://www.ncbi.nlm.nih.gov/pubmed/26958070 http://dx.doi.org/10.3345/kjp.2016.59.2.100 |
Ejemplares similares
-
Ceftriaxone-Induced Hemolytic Anemia in a Jehovah’s Witness
por: Tasch, James, et al.
Publicado: (2017) -
Successful Treatment of Severe Anemia using Erythropoietin in a Jehovah Witness with Non-Hodgkin Lymphoma
por: Agapidou, Alexandra, et al.
Publicado: (2014) -
The use of erythropoietin in a Jehovah's Witness undergoing major surgery and chemotherapy.
por: Johnson, P. W., et al.
Publicado: (1991) -
Thrombolytic therapy for critical limb ischemia in a Jehovah's Witness with severe anemia
por: Kauffman, Jeremy D., et al.
Publicado: (2017) -
Anesthetic management of Jehovah's Witness patients.
por: Kim, W. O.
Publicado: (1991)